Treat Ovarian Cancer With Genetics.
We’ve helped thousands of patients decide on their ovarian cancer treatment plan
When It Comes To Ovarian Cancer Trust the Innovators of the BRCA gene
Genetics testing provides critical information for making treatment decisions for ovarian cancer. 1 in 4 women with ovarian cancer will test positive to having a genetic mutation. Testing results will also inform you if you are at an elevated risk for additional cancers such as breast cancer, or if your family has an elevated risk for cancer and what preventative actions they can take.
What does Myriad provide?
Myriad Genetics is known for its industry leading accuracy. Armed with this information, you and your doctor no longer have to do trial and error. You can start creating a treatment plan that is personalized to you.
What is Hereditary Breast and Ovarian Cancer?
What Answers Do Each Test Provide?
HEREDITARY CANCER TESTING
OVARIAN CANCER TREATMENT TESTING -TO HELP DETERMINE WHICH PATIENTS MAY BE APPROPRIATE FOR PARP INHIBITOR THERAPY
MyChoice CDx allows you to decide you are eligible for PARP Inhibitor therapy. Each test gives you a clear yes or no answer.
Hereditary Cancer Testing for Hereditary Breast and Ovarian Cancer (BRCA1 and BRCA2)
BRACAnalysis ® is a genetic test that detects the presence of a BRCA1 or BRCA2 gene mutation. People with a mutation in either the BRCA1 or BRCA2 gene have risks of up to 87 percent for developing breast cancer and 39-63 percent for developing ovarian cancer by age 70.
OVARIAN CANCER TREATMENT OPTIONS
PositiveSelect Plus provides patients with treatment options such as chemotherapy, targeted therapy and immunotherapy options.
Tumor Normal Match For Ovarian Cancer Treatment Options
PositiveSelect Ultimate is a genetic test that tests both cancer cells as well as normal blood cells. In addition to the PositiveSelect Plus test benefits, PositiveSelect Ultimate identifies somatic and germ line mutations.
Why Hereditary Testing for Ovarian Cancer?
Knowing whether your cancer was caused by a genetic mutation will help guide treatment decisions, determine your risk of developing additional cancers (like breast cancer), and identify your close family members’ risks of having the same mutation (50% chance).
Individuals with an identified hereditary cancer risk have up to a 63% lifetime risk of developing ovarian cancer. They are also at a much higher risk of developing other cancers, such as breast and pancreatic cancer, than the general public.